Transformation to plasmablastic lymphoma in CLL upon ibrutinib treatment

Chronic lymphatic leukaemia (CLL) is the most common leukaemia in the Western world. Ibrutinib, a tyrosine kinase inhibitor, is the treatment of choice on relapse or p53-dysfunction. Richter’s transformation to diffuse large B cell lymphoma is most often seen. However, transformation to other aggres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Case Rep
Main Authors: Marvyin, Kristo, Tjønnfjord, Eirik Brekka, Breland, Unni Mathilde, Tjønnfjord, Geir Erland
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7526319/
https://ncbi.nlm.nih.gov/pubmed/32994268
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235816
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados